Korro Bio, Inc. (KRRO) stock
KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.61−0.70 (-4.89%)
Close on Nov 13, 2026Market cap $200.42MP/E –Yield –
Korro Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Korro Bio's price to sales ratio was 89.0× on Nov 11, 2026, against 7.3× a year earlier. Over the last 4 years it ranged from 1.2× to 103.5×, with a median of 10.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 89.0× | +78.7 |
| 2025 | Dec 31, 2025 | 10.2× | +7.4 |
| 2022 | Jul 29, 2022 | 2.9× | +0.0 |
| 2021 | Dec 31, 2021 | 2.8× | −11.6 |
| 2020 | Dec 31, 2020 | 14.4× | – |
See a number that looks wrong?